With rigorous economic research and practical policy solutions, we focus on the issues and institutions that are critical to global development. Explore our core themes and topics to learn more about our work.
In timely and incisive analysis, our experts parse the latest development news and devise practical solutions to new and emerging challenges. Our events convene the top thinkers and doers in global development.
As more countries rise out of poverty, CGD’s work in this area focuses on the inequities and emerging problems that jeopardize global health progress.
As more countries rise out of poverty, CGD is focusing on the inequities and emerging problems that jeopardize global health progress: How should governments allocate scarce health budgets rationally? How can global health donors and other development partners advance global health security, pandemic preparedness, and health systems strengthening? What can be done to address health inequities in low- and middle-income countries? What are evidence-informed policies to address market failures that span from early-stage pharmaceutical research and development to supply chain efficiency and ensure health product markets work for the poor?
CGD research helps policymakers build sustainable health systems, respond to shifting realities, and deliver value for money.
The Covid-19 pandemic has led to large budget gaps in low- and middle-income countries, with revenues projected to be reduced for years to come. This is the moment for policymakers to consider whether health taxes—levied on tobacco products, alcoholic and sugar-sweetened beverages, and polluting fuels—can play a part in boosting revenue while also supporting better health
Contact: Jeremy Gaines
Center for Global Development
+1 (202) 416-4058
With both President Biden and Prime Minister Johnson announcing increased contributions to COVAX, the Center for Global Development’s executive vice president Amanda Glassman, a global health expert and former principal technical lead for health at the Inter-American Development Bank, released the following statement:
“The Biden Administration's move to commit $4 billion to COVAX is a long-overdue step toward ending the pandemic globally, especially since the rise of new variants means that the only way to truly control COVID is to make sure everyone can get vaccinated—not just people in rich countries.”
“Timing is everything. We'd be in a different situation today if COVAX had been fully funded last March. But the world is better off than it was yesterday thanks these big new commitments from the US and UK. Rich countries should do more, because the sooner the funding is available, the sooner we can start dealing with problems like distributing vaccines around the globe.”
“Along with COVAX, wealthy countries need to commit to sharing excess vaccines. Overbuying made sense given how uncertain vaccine development is, but countries like the US, Canada, and the UK are soon going to have more vaccines than people. If we're serious about ending the pandemic, wealthy countries need to make plans now so they’re ready to share surplus vaccines as soon as their own populations are vaccinated.”
Millions Saved: Proven Success in Global Health details 17 cases in which large-scale efforts to improve health in developing countries have succeeded, saving millions of lives and preserving the livelihoods and social fabric of entire communities.
In this working paper, commissioned as part of CGD's Drug Resistance Working Group, Prashant Yadav analyzes how changes in supply-chain business practices could help fix the misaligned incentives that hinder worldwide access to high-quality medical goods.
This annual report marks two milestones in 2016: CGD’s 15th anniversary and, at the end of the year, its first leadership transition, with founding president Nancy Birdsall being succeeded by Masood Ahmed. In this first era, the Center has established itself as an influential voice in international development policy, with a unique model of nonpartisan policy innovation.
In a pathbreaking follow-up to the 2008 report Girls Count, Miriam Temin and CGD vice president Ruth Levine shed light on the reality of girls’ health worldwide and its enormous on the wellbeing and productivity of girls, their families, and their nations. Start with a Girl: A New Agenda for Global Health highlights successful efforts to break the cycle of ill health and proposes a comprehensive, practical health agenda that starts with adolescent girls.